A large batch of L800R high-capacity refrigerated centrifuges manufactured by Lu Xiangyi has been shipped to a pharmaceutical factory in Shandong.

Release time:

2019-06-11


Overview:

Recently, Shanghai Lushangyi has announced another significant piece of news: a pharmaceutical manufacturer in Shandong has placed another order for a batch of Shanghai Lushangyi L800R high-capacity refrigerated centrifuges.

  Shanghai Luxiangyi Centrifuge Instrument Co., Ltd. is a professional manufacturer. Centrifuge The company boasts a long-standing production history and strong technical capabilities, earning widespread acclaim within the industry. Recently, Shanghai Lushangyi announced another significant development: a pharmaceutical manufacturer in Shandong has placed another order for a batch of Shanghai Lushangyi’s L800R high-capacity refrigerated centrifuges.

00.jpg

002.jpg

  It is understood that the L800R high-capacity refrigerated centrifuge is specially designed for customers with large-volume requirements. This model boasts a high sample-processing capacity and is a professional product tailored for fields such as central blood banks, pharmaceuticals, and bioengineering. It can simultaneously separate 12 × 400 ml triple-bag or quadruple-bag units, or 24 × 200 ml triple-bag units. The centrifuge features an imported high-performance compressor unit and uses the fluorine-free refrigerant R404a, meeting environmental protection standards. In addition, this centrifuge is equipped with a powerful control system that enables the recall of pre-set segmented stepwise centrifugation programs and provides hierarchical password-based access control, ensuring safe and reliable instrument operation and facilitating fine-grained management.

003.jpg004.jpg

005.jpg

  As a high-tech technology, the pharmaceutical centrifuge used in biopharmaceutical production has opened up broad prospects for the development of related industries such as healthcare and pharmaceuticals, significantly improving people's quality of life and enhancing work and production efficiency. Consequently, biotechnology has been recognized worldwide as a key technology and emerging industry driving scientific and technological advancement in the 21st century.

  A biopharmaceutical centrifuge is a specialized piece of equipment designed for the separation of liquid-solid two-phase systems with fine solid particles and very similar specific gravities, as well as liquid-liquid-solid three-phase systems. It is an essential device in numerous industries, including pharmaceuticals, food processing, chemical engineering, biotechnology, and beverage production. The centrifuge operates on the principle of utilizing strong centrifugal force to effectively separate materials of different specific gravities, thereby achieving the desired separation.

  As the country continues to increase its investment in research and development of generic drugs and originator drugs, China’s pharmaceutical market has gradually shifted from being dominated by imported drugs to a market increasingly driven by domestic generics or originator drugs. Although China is currently still a major producer of generic drugs—with an enormous variety and number of generic drug formulations—most domestically produced generics still lag significantly behind originator drugs in terms of quality. However, as China’s pharmaceutical equipment and manufacturing technologies continue to improve, the quality and efficacy of domestically produced drugs will also achieve a qualitative leap, gradually narrowing the gap with imported originator drugs and eventually replacing them altogether.

  Shanghai Luxiangyi boasts a long history and strong technological capabilities. Since its establishment, the company has been committed to promoting the innovative development of domestically produced centrifuges. Currently, Shanghai Luxiangyi’s centrifuges have expanded into the international market, with exports reaching over 30 countries including the United States, Germany, the United Kingdom, Canada, and Thailand. While meeting domestic demand in China, the company has consistently focused on supporting the development of pharmaceutical enterprises. By continuously improving the manufacturing processes and enhancing the precision of its centrifuges, Shanghai Luxiangyi has provided valuable assistance to domestic pharmaceutical companies in meeting their needs for pharmaceutical centrifuges and contributing to their growth and development.

  It is understood that, after more than four decades of development, Shanghai Luxiangyi has successively designed and manufactured the domestically produced high-speed refrigerated centrifuge GL-25M and developed a continuous-flow rotor made of 316L stainless steel—a first for China. Building on the 2400ml square rotor, Shanghai Luxiangyi has also created a 2000ml round rotor that offers greater convenience for extraction in the pharmaceutical industry. This rotor comes equipped with a 316L stainless steel centrifuge cup, providing an excellent matching solution for pharmaceutical companies certified by regulatory authorities. The recent order placed by a pharmaceutical manufacturer in Shandong for Shanghai Luxiangyi’s L800R large-capacity refrigerated centrifuge further underscores the company’s commitment to product quality, technological prowess, and outstanding service.